Literature DB >> 3746824

Amino-substituted p-benzoquinones.

A E Mathew, R K Zee-Cheng, C C Cheng.   

Abstract

Based on the observation of outstanding antineoplastic activity of a number of amino-substituted anthraquinones, thioxanthones, and N-(aminoethyl)-substituted naphthalimides, four types of amino-substituted p-benzoquinones were designed, synthesized, and their biological activity evaluated. Although none of these compounds exhibited inhibitory activity against P388 leukemia, 2,5-bis[[4-[(dimethylamino)methyl]phenyl]amino]-3,6-dibromo-1,4- benzoquinone and the corresponding dichloro compound demonstrated good inhibitory activity against the proliferating human colon adenocarcinoma in vitro. The dichloro compound was also found to be active against the leukemia L1210 screening in vitro. 2,5-Bis[[2-(dimethylamino)ethyl]amino]-1,4-benzoquinone possessed inhibitory activity against Neisseria catarrhali.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3746824     DOI: 10.1021/jm00159a041

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Engineering and Applications of fungal laccases for organic synthesis.

Authors:  Adinarayana Kunamneni; Susana Camarero; Carlos García-Burgos; Francisco J Plou; Antonio Ballesteros; Miguel Alcalde
Journal:  Microb Cell Fact       Date:  2008-11-20       Impact factor: 5.328

2.  Half-Wave Potentials and In Vitro Cytotoxic Evaluation of 3-Acylated 2,5-Bis(phenylamino)-1,4-benzoquinones on Cancer Cells.

Authors:  Julio Benites; Jaime A Valderrama; Maryan Ramos; Maudy Valenzuela; Angélica Guerrero-Castilla; Giulio G Muccioli; Pedro Buc Calderon
Journal:  Molecules       Date:  2019-05-08       Impact factor: 4.411

3.  Design, synthesis and cytotoxic activity of water-soluble quinones with dibromo-p-benzoquinone cores and amino oligo(ethylene glycol) side chains against MCF-7 breast cancer cells.

Authors:  Leon F Scherz; Engy A Abdel-Rahman; Sameh S Ali; A Dieter Schlüter; Mona A Abdel-Rahman
Journal:  Medchemcomm       Date:  2017-02-16       Impact factor: 3.597

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.